Literature DB >> 7930229

Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans.

Y Hirooka1, K Egashira, T Imaizumi, T Tagawa, H Kai, M Sugimachi, A Takeshita.   

Abstract

OBJECTIVES: The goal of this study was to determine whether the effect of L-arginine on endothelium-dependent vasodilation evoked with acetylcholine differs between the coronary and forearm vasculatures in humans.
BACKGROUND: Administration of L-arginine, a substrate in the production of endothelium-derived nitric oxide, may stimulate the release of nitric oxide.
METHODS: Seven patients with normal coronary angiograms and seven with mild coronary artery disease and hypertension underwent coronary arteriography and an intracoronary Doppler catheter technique, and the diameter of the large epicardial coronary artery and coronary blood flow were measured. Forearm blood flow was measured by use of a strain gauge plethysmograph.
RESULTS: Before L-arginine administration, acetylcholine (1 to 30 micrograms/min) increased coronary blood flow with modest vasoconstriction of a large coronary artery. Acetylcholine (4 to 24 micrograms/min) also increased forearm blood flow. The acetylcholine-induced increases in coronary and forearm blood flow were significantly less in patients with coronary artery disease than in control patients. Intracoronary infusion of L-arginine at 50 mg/min did not alter responses of the large coronary artery diameter or coronary blood flow to acetylcholine in either group. In contrast, L-arginine at 10 mg/min significantly (p < 0.01) augmented the forearm blood flow response to acetylcholine (4 to 24 micrograms/min) to a similar extent in the two groups.
CONCLUSIONS: The effect of L-arginine on acetylcholine-induced vasodilation differs between the coronary and forearm vasculatures in humans. It is suggested that impaired acetylcholine-induced coronary and forearm vasodilation in patients with coronary artery disease and hypertension may not be related to a limited availability of L-arginine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930229     DOI: 10.1016/0735-1097(94)90854-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Effect of L-arginine administration on myocardial thallium-201 perfusion during exercise in patients with angina pectoris and normal coronary angiograms.

Authors:  H Fujita; H Yamabe; M Yokoyama
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

Review 3.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

4.  Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries.

Authors:  D Tousoulis; G J Davies; C Tentolouris; T Crake; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

Review 5.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Simultaneous Noninvasive Assessment of Systemic and Coronary Endothelial Function.

Authors:  Micaela Iantorno; Allison G Hays; Michael Schär; Rupa Krishnaswamy; Sahar Soleimanifard; Angela Steinberg; Matthias Stuber; Gary Gerstenblith; Robert G Weiss
Journal:  Circ Cardiovasc Imaging       Date:  2016-03       Impact factor: 7.792

7.  Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

Authors:  P Clarkson; M R Adams; A J Powe; A E Donald; R McCredie; J Robinson; S N McCarthy; A Keech; D S Celermajer; J E Deanfield
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

8.  Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P.

Authors:  D Tousoulis; C Tentolouris; T Crake; G Katsimaglis; C Stefanadis; P Toutouzas; G J Davies
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

Review 9.  Using advanced noninvasive imaging techniques to probe the links between regional coronary artery endothelial dysfunction and atherosclerosis.

Authors:  Micaela Iantorno; Robert G Weiss
Journal:  Trends Cardiovasc Med       Date:  2013-10-16       Impact factor: 6.677

10.  Non-invasive measurement of the haemodynamic effects of inhaled salbutamol, intravenous L-arginine and sublingual nitroglycerin.

Authors:  Anna Tahvanainen; Miia Leskinen; Jenni Koskela; Erkki Ilveskoski; Juha Alanko; Mika Kähönen; Tiit Kööbi; Lauri Lehtimäki; Eeva Moilanen; Jukka Mustonen; Ilkka Pörsti
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.